Xenon Pharmaceuticals Inc.

Xenon Pharmaceuticals a clinical-stage biopharmaceutical company discovering and developing a pipeline of differentiated therapeutics for orphan indications . They have built a core platform, which we call Extreme Genetics^®, enabling the discovery of validated drug targets by studying rare human diseases with extreme traits, including diseases caused by mutations in ion channels, known as channelopathies. Their integrated platform has a full complement of in-house capabilities for human genetics and small molecule drug discovery, and for pre-clinical and clinical development.